• 1
    Krasnokutsky S, Samuels J, Abramson SB.Osteoarthritis in 2007.Bull NYU Hosp Jt Dis2007;65:2228.
  • 2
    Pelletier JP, Martel-Pelletier J, Abramson SB.Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets [review].Arthritis Rheum2001;44:123747.
  • 3
    Ayral X, Dougados M, Listrat V, Bonvarlet JP, Simonnet J, Amor B.Arthroscopic evaluation of chondropathy in osteoarthritis of the knee.J Rheumatol1996;3:698706.
  • 4
    Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B.Synovial tissue inflammation in early and late osteoarthritis.Ann Rheum Dis2005;64:12637.
  • 5
    Vankemmelbeke MN, Holen I, Wilson AG, Ilic MZ, Handley CJ, Kelner GS, et al.Expression and activity of ADAMTS-5 in synovium.Eur J Biochem2001;268:125968.
  • 6
    Davidson RK, Waters JG, Kevorkian L, Darrah C, Cooper A, Donell ST, et al.Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.Arthritis Res Ther2006;8:R124.
  • 7
    Bondeson J, Blom AB, Wainwright S, Hughes C, Caterson B, van den Berg WB.The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis [review].Arthritis Rheum2010;62:64757.
  • 8
    Fosang AJ, Rogerson FM.Identifying the human aggrecanase [review].Osteoarthritis Cartilage2010;18:110916.
  • 9
    Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, et al.Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis.Nature2005;434:6448.
  • 10
    Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, et al.ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro.Nature2005;434:64852.
  • 11
    Song RH, Tortorella MD, Malfait AM, Alston JT, Yang Z, Arner EC, et al.Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.Arthritis Rheum2007;56:57585.
  • 12
    Wainwright SD, Bondeson J, Hughes CE.An alternative spliced transcript of ADAMTS4 is present in human synovium from OA patients.Matrix Biol2006;25:31720.
  • 13
    Rice P, Longden I, Bleasby A.EMBOSS: the European Molecular Biology Open Software Suite.Trends Genet2000;16:2767.
  • 14
    Amos N, Lauder S, Evans A, Feldman M, Bondeson J.Adenoviral gene transfer into osteoarthritis synovial cells using the endogenous inhibitor IκBα reveals that most, but not all, inflammatory and destructive mediators are NFκB dependent.Rheumatology (Oxford)2006;45:12019.
  • 15
    Hughes CE, Caterson B, Fosang AJ, Roughley P, Mort JS.Monoclonal antibodies that specifically recognize neoepitope sequences generated by ‘aggrecanase’ and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro.Biochem J1995;305:799804.
  • 16
    Heinegard D, Paulsson M. Structure and metabolism of proteoglycans. In: Piez K, Reddi A, editors.Extracellular matrix biochemistry.New York:Elsevier;1984. p.277328.
  • 17
    Rees SG, Flannery CR, Little CB, Hughes CE, Caterson B, Dent CM.Catabolism of aggrecan, decorin and biglycan in tendon.Biochem J2000;350:1818.
  • 18
    Bidanset DJ, Guidry C, Rosenberg LC, Choi HU.Binding of the proteoglycan decorin to collagen type VI.J Biol Chem1992;267:52506.
  • 19
    Tortorella MD, Arner EC, Hills R, Gormley J, Fok K, Pegg L, et al.ADAMTS-4 (aggrecanase-1): N-terminal activation mechanisms.Arch Biochem Biophys2005;444:3444.
  • 20
    Flannery CR, Zeng W, Corcoran C, Collins-Racie LA, Chockalingam PS, Hebert T, et al.Autocatalytic cleavage of ADAMTS-4 (aggrecanase-1) reveals multiple glycosaminoglycan-binding sites.J Biol Chem2002;277:4277580.
  • 21
    Gao G, Westling J, Thompson VP, Howell TD, Gottschall PE, Sandy JD.Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation.J Biol Chem2002;277:1103441.
  • 22
    Tortorella M, Pratta M, Lin RQ, Abbaszade I, Ross H, Burn T, et al.The thrombospondin motif of aggrecanase-1 (ADAMTS-4) is critical for aggrecan substrate recognition and cleavage.J Biol Chem2000;275:257917.
  • 23
    Westling J, Gottschall PE, Thompson VP, Cockburn A, Perides G, Zimmermann DR, et al.ADAMTS4 (aggrecanase-1) cleaves human brain versican V2 at Glu405–Gln406 to generate glial hyaluronate binding protein.Biochem J2004;377:78795.
  • 24
    Nakamura H, Fujii Y, Inoki I, Sugimoto K, Tanzawa K, Matsuki H, et al.Brevican is degraded by matrix metalloproteinases and aggrecanase-1 (ADAMTS4) at different sites.J Biol Chem2000;275:3888590.
  • 25
    Melching LI, Fisher WD, Lee ER, Mort JS, Roughley PJ.The cleavage of biglycan by aggrecanases.Osteoarthritis Cartilage2006;14:114754.
  • 26
    Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itol Y, et al.Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing.J Biol Chem2004;279:1010919.
  • 27
    Tsuji A, Sakurai K, Kiyokage E, Yamazaki T, Koide S, Toida K, et al.Secretory proprotein convertases PACE4 and PC6A are heparin-binding proteins which are localized in the extracellular matrix: potential role of PACE4 in the activation of proproteins in the extracellular matrix.Biochim Biophys Acta2003;1645:95104.
  • 28
    Malfait AM, Arner EC, Song RH, Alston JT, Markosyan S, Staten N, et al.Proprotein convertase activation of aggrecanases in cartilage in situ.Arch Biochem Biophys2008;478;4351.
  • 29
    Gao G, Plaas A, Thompson VP, Jin S, Zuo F, Sandy JD.ADAMTS4 (aggrecanase-1) activation on the surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparin sulfate on syndecan-1.J Biol Chem2004;279:1004251.
  • 30
    Blom AB, van den Berg WB. The synovium and its role in osteoarthritis. In: Bronner F, Farach-Carson MC, editors. Bone and osteoarthritis. Vol.4.New York:Springer-Verlag;2007. p.6579.